| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |